Share on LinkedInShare on LinkedIn

ARTICLE · 20 APRIL 2018

New Jury Imposes Disproportionate Punitive Award In AbbVie Retrial

Mayer Brown
Mayer Brown
Contributor
Mayer Brown

Mayer Brown

Mayer Brown is a leading international law firm positioned to represent the world’s major...

View firm profile
Explore more from Mayer Brown

Only three months after AbbVie obtained a retrial of a case in which a jury had imposed $150 million in punitive damages without awarding any compensatory damages, a new jury awarded...

United StatesLitigation, Mediation & Arbitration

Only three months after AbbVie obtained a retrial of a case in which a jury had imposed $150 million in punitive damages without awarding any compensatory damages, a new jury awarded the same plaintiff $200,000 in compensatory damages and $3 million in punitive damages.

As Andy Frey and I discussed in our post about the initial verdict, the plaintiff in the case alleges that he suffered a heart attack as a result of using AndroGel, a treatment for low testosterone. The jury found that AbbVie was negligent but found against the plaintiff on his fraudulent misrepresentation claim.

Not counting the original verdict, which was overturned in December, this is the second disproportionate punitive award imposed against AbbVie in litigation supervised by the same district court. The other punitive award is much higher ($140 million) and even more disproportionate (1,000 times the compensatory damages). The district court has still not ruled on the post-trial motions in

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from